Everett Harris & CO Becton Dickinson & CO Transaction History

Everett Harris & CO

  • $8 Billion
  • Q3 2024

A detailed history of Everett Harris & CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Everett Harris & CO holds 567,362 shares of BDX stock, worth $133 Million. This represents 1.71% of its overall portfolio holdings.

Number of Shares
567,362
Previous 568,767 0.25%
Holding current value
$133 Million
Previous $133 Million 2.91%
% of portfolio
1.71%
Previous 1.71%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
SELL
$221.47 - $242.41 $311,165 - $340,586
-1,405 Reduced 0.25%
567,362 $137 Million
Q2 2024

Aug 01, 2024
SELL
$225.07 - $246.17 $471,296 - $515,479
-2,094 Reduced 0.37%
568,767 $133 Million
Q1 2024

Apr 19, 2024
SELL
$233.45 - $247.73 $555,144 - $589,101
-2,378 Reduced 0.41%
570,861 $141 Million
Q4 2023

Jan 18, 2024
SELL
$232.24 - $267.23 $237,581 - $273,376
-1,023 Reduced 0.18%
573,239 $140 Million
Q3 2023

Oct 23, 2023
SELL
$254.9 - $283.59 $1.51 Million - $1.67 Million
-5,906 Reduced 1.02%
574,262 $148 Million
Q2 2023

Jul 26, 2023
BUY
$238.39 - $265.32 $24.5 Million - $27.3 Million
102,890 Added 21.56%
580,168 $153 Million
Q1 2023

Apr 24, 2023
BUY
$229.71 - $259.35 $158,040 - $178,432
688 Added 0.14%
477,278 $118 Million
Q4 2022

Jan 20, 2023
BUY
$218.29 - $256.91 $166,555 - $196,022
763 Added 0.16%
476,590 $0
Q3 2022

Oct 21, 2022
SELL
$51.03 - $264.23 $465,240 - $2.41 Million
-9,117 Reduced 1.88%
475,827 $106 Million
Q2 2022

Jul 22, 2022
SELL
$234.74 - $275.42 $247,885 - $290,843
-1,056 Reduced 0.22%
484,944 $120 Million
Q1 2022

Apr 22, 2022
BUY
$243.64 - $270.48 $124,500 - $138,215
511 Added 0.11%
486,000 $129 Million
Q4 2021

Feb 02, 2022
BUY
$230.08 - $250.94 $532,405 - $580,675
2,314 Added 0.48%
485,489 $122 Million
Q3 2021

Nov 03, 2021
SELL
$232.72 - $256.47 $279,729 - $308,276
-1,202 Reduced 0.25%
483,175 $119 Million
Q2 2021

Jul 29, 2021
SELL
$232.65 - $254.58 $94,455 - $103,359
-406 Reduced 0.08%
484,377 $118 Million
Q1 2021

May 13, 2021
SELL
$232.09 - $256.88 $647,066 - $716,181
-2,788 Reduced 0.57%
484,783 $118 Million
Q4 2020

Feb 04, 2021
BUY
$221.92 - $245.94 $1.02 Million - $1.13 Million
4,590 Added 0.95%
487,571 $122 Million
Q3 2020

Nov 03, 2020
BUY
$215.77 - $276.76 $3.08 Million - $3.95 Million
14,269 Added 3.04%
482,981 $112 Million
Q2 2020

Jul 29, 2020
BUY
$219.9 - $263.41 $10.7 Million - $12.8 Million
48,572 Added 11.56%
468,712 $112 Million
Q1 2020

Apr 29, 2020
BUY
$195.69 - $279.01 $5.66 Million - $8.07 Million
28,934 Added 7.4%
420,140 $96.5 Million
Q4 2019

Jan 27, 2020
SELL
$236.45 - $266.82 $3,546 - $4,002
-15 Reduced -0.0%
391,206 $106 Million
Q3 2019

Nov 06, 2019
SELL
$230.58 - $256.08 $141,114 - $156,720
-612 Reduced 0.16%
391,221 $99 Million
Q2 2019

Aug 13, 2019
BUY
$217.4 - $246.08 $81,525 - $92,280
375 Added 0.1%
391,833 $98.7 Million
Q1 2019

May 13, 2019
SELL
$206.05 - $248.17 $1.31 Million - $1.58 Million
-6,370 Reduced 1.6%
391,458 $97.8 Million
Q4 2018

Feb 13, 2019
SELL
$204.73 - $257.93 $708,365 - $892,437
-3,460 Reduced 0.86%
397,828 $89.6 Million
Q3 2018

Nov 14, 2018
SELL
$233.07 - $256.0 $533,264 - $585,728
-2,288 Reduced 0.57%
401,288 $105 Million
Q2 2018

Jul 27, 2018
SELL
$208.1 - $233.85 $760,189 - $854,254
-3,653 Reduced 0.9%
403,576 $96.7 Million
Q1 2018

Apr 20, 2018
BUY
$205.46 - $240.27 $1.18 Million - $1.38 Million
5,760 Added 1.43%
407,229 $88.2 Million
Q4 2017

Feb 01, 2018
SELL
$189.0 - $222.64 $81,648 - $96,180
-432 Reduced 0.11%
401,469 $85.9 Million
Q3 2017

Oct 11, 2017
BUY
$186.89 - $198.9 $75.1 Million - $79.9 Million
401,901
401,901 $78.8 Million

Others Institutions Holding BDX

# of Institutions
1,736
Shares Held
253M
Call Options Held
586K
Put Options Held
656K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $66.6B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Everett Harris & CO Portfolio

Follow Everett Harris & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

News

Stay updated on Everett Harris & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email